Dominique Herve

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 82 publications

Risk of Clinical Events in Presymptomatic Familial Cerebral Cavernous Malformations.

Risk of Clinical Events in Presymptomatic Familial Cerebral Cavernous Malformations.

Journal: European journal of neurology

Published: March 04, 2026

Tocotrienol-rich vitamin E complex in CADASIL (T3CAD): a randomised, double-blind, placebo-controlled trial.

Tocotrienol-rich vitamin E complex in CADASIL (T3CAD): a randomised, double-blind, placebo-controlled trial.

Journal: EClinicalMedicine

Published: February 21, 2026

COL4A1 and COL4A2 Gene Duplication or Triplication as a Genetic Cause of Cerebral Small Vessel Disease in Adults.

COL4A1 and COL4A2 Gene Duplication or Triplication as a Genetic Cause of Cerebral Small Vessel Disease in Adults.

Journal: Stroke

Published: January 02, 2026

Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL.

Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL.

Journal: Annals of clinical and translational neurology

Published: December 26, 2025

Simple MRI Lesion Levels Improve Two-Year Prognostic Accuracy Beyond Clinical History in CADASIL.

Simple MRI Lesion Levels Improve Two-Year Prognostic Accuracy Beyond Clinical History in CADASIL.

Journal: Stroke

Published: December 24, 2025

Response to the Letter to the Editor: "Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy".

Response to the Letter to the Editor: "Reaffirming Caution-The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy".

Journal: European journal of neurology

Published: November 12, 2025

Lifetime Risk of First Symptomatic ICH or Seizure in Familial Cerebral Cavernous Malformations: A Multicenter Patient Data Analysis.

Lifetime Risk of First Symptomatic ICH or Seizure in Familial Cerebral Cavernous Malformations: A Multicenter Patient Data Analysis.

Journal: Neurology

Published: July 10, 2025

The Spectrum of Headaches in Moyamoya Angiopathy: From Mechanisms to Management Strategies-A Consensus Review From the NEUROVASC Working Group.

The Spectrum of Headaches in Moyamoya Angiopathy: From Mechanisms to Management Strategies-A Consensus Review From the NEUROVASC Working Group.

Journal: European journal of neurology

Published: May 31, 2025

Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?

Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?

Journal: Stroke

Published: April 24, 2025

Time to consider health services dedicated for adults living with cerebral small vessel disease: Report of a ESO scientific seminar.

Time to consider health services dedicated for adults living with cerebral small vessel disease: Report of a ESO scientific seminar.

Journal: European stroke journal

Published: January 10, 2025

Determining Clinical Disease Progression in Symptomatic Patients With CADASIL.

Determining Clinical Disease Progression in Symptomatic Patients With CADASIL.

Journal: Neurology

Published: December 17, 2024

Moyamoya Angiopathy and Antiphospholipid Antibodies: A Coincidental Association?

Moyamoya Angiopathy and Antiphospholipid Antibodies: A Coincidental Association?

Journal: Stroke

Published: December 09, 2024

Showing 1-12 of 82

Last Updated: 09/26/2026